Tribavirin
RxNorm 9344
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 9344 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tribavirin.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing ribavirin (medicinal product)
(Atom ID: 9262189)
INPrescribable
Ingredient (IN):
Ribavirin
(Atom ID: 12254516)
PTPrescribable
Designated preferred name (PT):
Ribavirin
(Atom ID: 300464)
FNPrescribable
Full form of descriptor (FN):
Ribavirin (substance)
(Atom ID: 300486)
PTPrescribable
Designated preferred name (PT):
Ribavirin-containing product
(Atom ID: 10820272)
SYPrescribable
Synonym (SY):
RTCA
(Atom ID: 300483)
SYPrescribable
Synonym (SY):
Tribavirin
(Atom ID: 300477)
Patient Education
Ribavirin
Ribavirin is used with an interferon medication such as peginterferon alfa-2a [Pegasys] or peginterferon alpha-2b [PEG-Intron]) to treat hepatitis C in people who have not been treated with an interferon before. Ribavirin is in a class of antiviral medications called nucleoside analogues. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if treatment that includes ribavirin and another medication cures hepatitis C infection, prevents liver damage that may be caused by hepatitis C, or prevents the spread of hepatitis C to other people.
[Learn More]
* Please review the disclaimer below.